Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Beta-casein Polyclonal Antibody, RBITC Conjugated

Product Specifications

Background

Important role in determination of the surface properties of the casein micelles. Casoparan acts as a macrophage activator, increasing the phagocytic activity of macrophages and peroxide release from macrophages. It also acts as a bradykinin-potentiating peptide. Casohypotensin acts as a bradykinin-potentiating peptide. Induces hypotension in rats. Acts as a strong competitive inhibitor of endo-oligopeptidase A. Antioxidant peptide has antioxidant activity.

Synonyms

Beta-casein; CSN2

Gene ID

281099

Swiss Prot

P02666

Cellular Locus

Secreted

Host

Rabbit

Cross Reactivity

Human, Goat, Cow

Immunogen

16-100/224

Target

Beta-casein

Clonality

Polyclonal

Isotype

IgG

Conjugation

RBITC

Source

KLH conjugated synthetic peptide derived from bovine Beta-casein

Applications

WB

Purification

Purified by Protein A.

Excitation Emission

570nm/595nm

Concentration

1µg/µl

Dilution

WB (1:300-5000)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

281099

Predicted Cross Reactivity

Sheep

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human MDGA2 Pre-designed siRNA Set A
SI009381A 1 Each

Human MDGA2 Pre-designed siRNA Set A

Ask
View Details
GENLISA Human Leukocyte Antigen B27 (HLA-B27) ELISA
KBH12659 1x 96 Well

GENLISA Human Leukocyte Antigen B27 (HLA-B27) ELISA

Ask
View Details
Caplacizumab (Biosimilar Reference Antibody) (VWF)
RA0819-01 100 µg

Caplacizumab (Biosimilar Reference Antibody) (VWF)

Ask
View Details
Caplacizumab (Biosimilar Reference Antibody) (VWF)
RA0819-02 1 mg

Caplacizumab (Biosimilar Reference Antibody) (VWF)

Ask
View Details
Caplacizumab (Biosimilar Reference Antibody) (VWF)
RA0819-03 5 mg

Caplacizumab (Biosimilar Reference Antibody) (VWF)

Ask
View Details
Caplacizumab (Biosimilar Reference Antibody) (VWF)
RA0819-04 10 mg

Caplacizumab (Biosimilar Reference Antibody) (VWF)

Ask
View Details